Small for Gestational AgeSymptoms, Doctors, Treatments, Advances & More
Learn About Small for Gestational Age
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
The Delaware Center For Maternal And Fetal Medicine Of Christiana Care
Suneet Chauhan is an Obstetrics and Gynecologist practicing medicine in Newark, Delaware. Dr. Chauhan is rated as an Elite provider by MediFind in the treatment of Small for Gestational Age. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Intrauterine Growth Restriction, Intraventricular Hemorrhage of the Newborn, Small for Gestational Age, Hysterectomy, and Salpingo-Oophorectomy. Dr. Chauhan is board certified in American Board Of Obstetrics And Gynecology.
Women & Infants Hospital Of Rhode Island
Methodius Tuuli is a Neonatologist and an Obstetrics and Gynecologist practicing medicine in Providence, Rhode Island. Dr. Tuuli is rated as an Elite provider by MediFind in the treatment of Small for Gestational Age. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Small for Gestational Age, Intrauterine Growth Restriction, Endometritis, Hysterectomy, and Intrauterine Device Insertion.
OHSU Hospital
Aaron Caughey is a Neonatologist and an Obstetrics and Gynecologist practicing medicine in Portland, Oregon. Dr. Caughey is rated as an Elite provider by MediFind in the treatment of Small for Gestational Age. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Gestational Diabetes, Endometritis, Preeclampsia, Intrauterine Device Insertion, and Hysterectomy.
Summary: This basket trial will enroll prepubertal children and adolescents with clinically diagnosed and genetically confirmed (if applicable) TS, SHOX-D, SGA, or ISS between ages of ≥2 and \<18 years with open growth plates. The purpose of the study is to see how well treatment with once-weekly lonapegsomatropin works compared to treatment with daily somatropin. Approximately 186 participants will be dis...
Summary: This study is a randomized, open-label, active controlled, parallel group study comparing the efficacy and safety of once weekly Somatrogon to daily Growth Hormone (Genotropin) in pre-pubertal children with short stature either born Small for Gestational Age (SGA) or with Idiopathic Short Stature (ISS). The planned study duration is 12 months with a screening period of up to 30 days. The study wil...